Sila Realty Trust (NYSE:SILA) Hits New 52-Week High After Dividend Announcement

Sila Realty Trust, Inc. (NYSE:SILA) hit a new 52-week high on Wednesday following a dividend announcement from the company. The company traded as high as $30.61 and last traded at $30.5750, with a volume of 511668 shares changing hands. The stock had previously closed at $30.43.

The newly announced dividend which will be paid on Thursday, June 4th. Shareholders of record on Wednesday, May 20th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 5.2%. The ex-dividend date of this dividend is Wednesday, May 20th. Sila Realty Trust’s payout ratio is presently 275.86%.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on SILA. Truist Financial set a $28.00 target price on shares of Sila Realty Trust in a research note on Wednesday, March 11th. Wall Street Zen cut shares of Sila Realty Trust from a “hold” rating to a “sell” rating in a research note on Saturday, April 25th. Freedom Capital cut shares of Sila Realty Trust from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 21st. Wells Fargo & Company boosted their price objective on shares of Sila Realty Trust from $25.00 to $30.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 21st. Finally, Zacks Research raised shares of Sila Realty Trust to a “hold” rating in a research note on Tuesday, March 3rd. Six equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $29.00.

Sila Realty Trust Trading Down 0.0%

The company has a market cap of $1.69 billion, a P/E ratio of 52.72 and a beta of 1.01. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.51. The firm’s 50 day moving average is $25.97 and its two-hundred day moving average is $24.59.

Sila Realty Trust (NYSE:SILA) last released its earnings results on Thursday, May 7th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.02. The business had revenue of $52.67 million for the quarter, compared to analyst estimates of $49.77 million. Sila Realty Trust had a net margin of 16.36% and a return on equity of 2.39%. As a group, equities research analysts anticipate that Sila Realty Trust, Inc. will post 2.24 EPS for the current year.

Hedge Funds Weigh In On Sila Realty Trust

Hedge funds and other institutional investors have recently bought and sold shares of the company. Golden State Wealth Management LLC lifted its holdings in Sila Realty Trust by 87.6% in the fourth quarter. Golden State Wealth Management LLC now owns 1,071 shares of the company’s stock valued at $25,000 after buying an additional 500 shares during the period. Entrust Financial LLC acquired a new position in Sila Realty Trust in the fourth quarter valued at $29,000. Newbridge Financial Services Group Inc. lifted its holdings in Sila Realty Trust by 90.4% in the third quarter. Newbridge Financial Services Group Inc. now owns 1,232 shares of the company’s stock valued at $31,000 after buying an additional 585 shares during the period. Basepoint Wealth LLC acquired a new position in Sila Realty Trust in the fourth quarter valued at $30,000. Finally, United Financial Planning Group LLC acquired a new position in Sila Realty Trust in the third quarter valued at $35,000.

About Sila Realty Trust

Sila Realty Trust, Inc, headquartered in Tampa, Florida, is a net lease real estate investment trust with a strategic focus on investing in the large, growing, and resilient healthcare sector. The Company invests in high quality healthcare facilities along the continuum of care, which, we believe, generate predictable, durable, and growing income streams. Our portfolio comprises high quality tenants in geographically diverse facilities, which are positioned to capitalize on the dynamic delivery of healthcare to patients.